DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Indatraline
Indatraline
(19) United States (12) Patent Application Publication (10) Pub
RTI-4793-14, a New Ligand with High Affinity and Selectivity For
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Compositions and Methods for Selective Delivery of Oligonucleotide Molecules to Specific Neuron Types
Selective Knockdown of TASK3 Potassium Channel in Monoamine
(12) United States Patent (10) Patent No.: US 7,893,053 B2 Seed Et Al
Ep 0790250 A2
Pharmaceuticals Appendix
(12) United States Patent (10) Patent No.: US 7,160,899 B2 Peters Et Al
Neurochemical Neutralization of Methamphetamine with High
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
I (Acts Whose Publication Is Obligatory) COMMISSION
Involvement of Serotonergic System in Oxaliplatin-Induced Neuropathic Pain
Antidepressant Indatraline Induces Autophagy and Inhibits Restenosis
Small Molecules for Fat Combustion: Targeting Thermosensory and Satiety
Interaction of Amphetamines and Related Compounds at the Vesicular Monoamine Transporter
Treatment of Adhd Behandlung Von Adhd Traitement Du Thada
Top View
Indatraline: Synthesis and Effect on the Motor Activity of Wistar Rats
Antagonism of Nicotinic Acetylcholine Receptors by Inhibitors of Monoamine Uptake HE Lo´Pez-Valde´S and J Garcı´A-Colunga
Rana Dadashova
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
3,4-Methylenedioxypyrovalerone (MDPV)
Certificate of Analysis
The Actions of Dopamine and Psychostimulants Mark S
Development of MS Binding Assays Addressing the Human Dopamine, Norepinephrine, and Serotonin Transporter
Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures S
Pharmaabkommen A1 E
Neurochemical Neutralization of Methamphetamine With
Known Bioactive Library: Tocriscreen Mini Library 2
Customs Tariff - Schedule Xxi - 1
Pharmacological Profile of Methylphenidate-Based Designer Drugs
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
Harmonized Tariff Schedule of the United States (2006) (Rev
Wo 2007/147134 A2
WO 2016/135707 Al 1 September 2016 (01.09.2016) P O P C T
Table [1]: Definition of Reported Outcomes Study Outcome
Synergy Between Growth Factors and Transmitters Required for Catecholamine Differentiation in Brain Neurons
Subject Index Volume 25
1 Dose-Dependent Naloxone-Induced Morphine Withdrawal Symptoms in Opioid-Dependent Males - a Double-Blinded, Randomized Study
(12) Patent Application Publication (10) Pub. No.: US 2005/0085463 A1 Weiner Et Al
Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*Α-Synuclein Transgenic Mice
Joseph H. Porter · Adam J. Prus Editors the Behavioral Neuroscience of Drug Discrimination Current Topics in Behavioral Neurosciences
(12) United States Patent (10) Patent No.: US 8,957,099 B2 Bird (45) Date of Patent: Feb
Effects of Indatraline and Buprenorphine on Self-Administration of Speedball Combinations of Cocaine and Heroin by Rhesus Monkeys Nancy K
Supplementary Material
School Ofmedicine Oregon Health & Science University CERTIFICATE
Pharmaceutical Appendix to the Tariff Schedule 2
Supplementary Table S1. List of 252 Drugs from the Prestwick Chemical Library No
Problems of Drug Dependence, 1993: Proceedings of the 55Th Annual Scientific Meeting the College on Problems of Drug Dependence, Inc
Pharmaceuticals Appendix
Known Bioactive Library: LOPAC 1
Lack of Influence of Substrate on Ligand Interaction with the Human Multidrug and Toxin Extruder, MATE1 S
Schedule Clxxiii - European Union
The Actions of Dopamine and Psychostimulants
A New Class of Antidepressant Drugs in the Treatment of Psychiatric Disorders: the Triple Reuptake Inhibitors